| AD | Alzheimer’s disease |
| A3SS | alternative 3′ splice site |
| A5SS | alternative 5′ splice site |
| AS | alternative splicing |
| Aβ | β-amyloid |
| BP | biological process |
| CBD | cannabidiol |
| CBG | cannabigerol |
| CBNR | cannabinerol |
| DAG | directed acyclic graph |
| DASE | differential alternative splicing event |
| DEG | differentially expressed gene |
| FDR | false discovery rate |
| GO | Gene Ontology |
| GWAS | genome-wide association studies |
| IGV | Integrative Genomics Viewer |
| lncRNA | long non-coding RNA |
| MFE | Minimum Free Energy |
| miRNA | microRNA |
| MXE | mutually exclusive exon |
| ncRNA | non-coding RNA |
| NMD | nonsense-mediated decay |
| ORA | over-representation analysis |
| ORF | open reading frame |
| PSI | Percent Spliced In |
| RA | retinoic acid |
| RI | retained intron |
| rMATS | replicate Multivariate Analysis of Transcript Splicing |
| SE | skipped exon |
| sncRNAs | small non-coding RNAs |
| Δ8-THC | ∆8-tetrahydrocannabinol |
| Δ9-THC | Δ9-tetrahydrocannabinol |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.